Bovin beta-1,4-Galactosyltransferase 1 (Y289L) CAS#: 24-1-1060

By Christina Duan,
IdentificationPhysical DataSpectra
Route of Synthesis (ROS)Safety and HazardsOther Data

Identification

英文名Bovin beta-1,4-Galactosyltransferase 1 (Y289L)
分子结构
CAS编号 24-1-1060
别名
分子式
分子量
InChI
InChI Key
Canonical SMILES

Physical Data

AppearanceWhite freeze-dried powder

Spectra

No data available

Route of Synthesis (ROS)

No data available

Safety and Hazards

GHS Hazard Statements
Not Classified

Source: European Chemicals Agency (ECHA)
License Note: Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: “Source: European Chemicals Agency, http://echa.europa.eu/”. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
License URL: https://echa.europa.eu/web/guest/legal-notice
Record Name: (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate
URL: https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/213446
Description: The information provided here is aggregated from the “Notified classification and labelling” from ECHA’s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database

Other Data

Use Pattern
Bovine B4GALT1(Y289L) is a mutant galactosyltransferase capable of efficiently transferring GalNAc or GalNAz onto terminal GlcNAc residues. This enzyme is particularly useful in the synthesis of antibody-drug conjugates (ADCs), which are applied in targeted cancer therapies and other biomedical applications.